File(s) under permanent embargo
A targeted siRNA based screen to identify calcium transporters involved in the calcium-dependent regulation of ABCC3 gene expression in a model of breast cancer epithelial-mesenchymal transition (EMT) [Poster]
Introduction: Invasion and metastasis are hallmarks of cancer and are linked to resistance to anticancer therapies. Increased expression of members of the ATP-binding cassette (ABC) transporter superfamily is also implicated in resistance to chemotherapeutics, and has been linked to invasive behaviour. We have previously identified the Ca2+- dependent upregulation of ABCC3 gene expression in a model of breast cancer epithelial-mesenchymal transition (EMT), a process involved in metastasis. The Ca2+ transporter(s) involved in the regulation of ABCC3 gene expression in this model of EMT are yet to be identified.
Aims: To identify the Ca2+ channels and/or pumps involved in the Ca2+-dependent upregulation of ABCC3 transporter gene expression in a breast cancer model of epidermal growth factor (EGF)-induced EMT.
Methods: To assess the role of Ca2+ transporters in ABCC3 gene expression, an siRNA-based screen targeting 24 Ca2+ channels and pumps using Dharmacon On-TARGETplus SMARTpool siRNAs was performed. MDA-MB-468 basal-like breast cancer cells were transfected with each siRNA SMARTpool for 48 h. Following transfection, cells were serum starved (0.5% FBS) for 24 h before induction of EMT via treatment with EGF (50 ng/mL) for 48 h. Quantitative RT-PCR was used to assess changes in ABCC3 mRNA expression following siRNA and EGF treatment.
Results: siRNA mediated silencing of the Ca2+ permeable ion channel, TRPM7, a previously characterised partial regulator of EMT in this model, did not inhibit ABCC3 gene expression following 24 h EGF treatment. However, siRNA screening identified other Ca2+ transporters that may act as potential regulators of EGF-induced ABCC3 expression at 48 h, for further characterisation.
Discussion: Induction of EMT by EGF in MDA-MB-468 breast cancer cells results in the Ca2+-dependent upregulation of ABCC3 transporter gene expression. Further studies are required to characterise the Ca2+ transporters involved in the regulation of ABCC3 expression in this model.
History
Publication title
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting (ASCEPT2013)Pagination
132Department/School
School of Pharmacy and PharmacologyPublisher
Australasian Society of Clinical and Experimental Pharmacologists and ToxicologistsPlace of publication
AustraliaEvent title
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting (ASCEPT2013)Event Venue
Melbourne, AustraliaDate of Event (Start Date)
2013-12-01Date of Event (End Date)
2013-12-04Repository Status
- Restricted